Melanoma NOS1 expression promotes dysfunctional IFN signaling

The stable traits of melanoma genetics: an alternate approach to target discovery

(2012) Tara L Spivey et al.   BMC GENOMICS

Reflections upon human cancer immune responsiveness to T cell-based therapy

(2012) Ena Wang et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Induced and natural regulatory T cells in human cancer

(2012) Theresa L. Whiteside et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

The immune score as a new possible approach for the classification of cancer

(2012) Jérôme Galon et al.   Journal of Translational Medicine

A genetic inference on cancer immune responsiveness

(2012) Ena Wang et al.   OncoImmunology

Phenotype, function and clinical implications of myeloid-derived suppressor cells in cancer patients

(2011) Paola Filipazzi et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Clinical Impact of Different Classes of Infiltrating T Cytotoxic and Helper Cells (Th1, Th2, Treg, Th17) in Patients with Colorectal Cancer

(2011) Marie Tosolini et al.   CANCER RESEARCH

Molecular Insights on the Peripheral and Intratumoral Effects of Systemic High-Dose rIL-2 (Aldesleukin) Administration for the Treatment of Metastatic Melanoma

(2011) G. R. Weiss et al.   CLINICAL CANCER RESEARCH

Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy

(2011) S. A. Rosenberg et al.   CLINICAL CANCER RESEARCH

Interferon signaling patterns in peripheral blood lymphocytes may predict clinical outcome after high-dose interferon therapy in melanoma patients

(2011) Diana L Simons et al.   Journal of Translational Medicine

An immunologic portrait of cancer

(2011) Maria Ascierto et al.   Journal of Translational Medicine

Nitric oxide and protein phosphatase 2A provide novel therapeutic opportunities in ER-negative breast cancer

(2011) Christopher H. Switzer et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

CD8+ Enriched "Young" Tumor Infiltrating Lymphocytes Can Mediate Regression of Metastatic Melanoma

(2010) M. E. Dudley et al.   CLINICAL CANCER RESEARCH

Increased NOS2 predicts poor survival in estrogen receptor–negative breast cancer patients

(2010) Sharon A. Glynn et al.   JOURNAL OF CLINICAL INVESTIGATION

Impaired STAT Phosphorylation in T Cells from Melanoma Patients in Response to IL-2: Association with Clinical Stage

(2009) R. Mortarini et al.   CLINICAL CANCER RESEARCH

Genomic scale analysis of racial impact on response to IFN- 

(2009) Z. Pos et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Impaired interferon signaling is a common immune defect in human cancer

(2009) R. J. Critchley-Thorne et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Conservation of Genetic Alterations in Recurrent Melanoma Supports the Melanoma Stem Cell Hypothesis

(2008) M. Sabatino et al.   CANCER RESEARCH

Gene Expression Profiling Reveals Similarities between the In vitro and In vivo Responses of Immune Effector Cells to IFN- 

(2008) J. M. Zimmerer et al.   CLINICAL CANCER RESEARCH

Signaling Molecules: The Pathogenic Role of the IL-6/STAT-3 Trans Signaling Pathway in Intestinal Inflammation and in Colonic Cancer

(2008) R. Atreya et al.   CURRENT DRUG TARGETS

More insights into the immunosuppressive potential of tumor exosomes

(2008) Veronica Huber et al.   Journal of Translational Medicine

The immunologic constant of rejection

(2008) Ena Wang et al.   TRENDS IN IMMUNOLOGY